Many experts agree that polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome, better reflects the hormonal and metabolic aspects of the condition. Some argue that PMOS still falls short in becoming a comprehensive moniker for the complex syndrome.
Many experts agree that polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome, better reflects the hormonal and metabolic aspects of the condition.
Some argue that PMOS still falls short in becoming a comprehensive moniker for the complex syndrome.
Anuja Dokras, MD, MHCI, PhD, director of the Penn Polyendocrine Metabolic Syndrome Center and Founder's Professor of Women's Health at the University of Pennsylvania, was one of the senior authors of the...
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
Many experts agree that polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome, better reflects the hormonal and metabolic aspects of the condition. Some argue that PMOS still falls short in becoming a comprehensive moniker for the complex syndrome. Anuja Dokras, MD, MHCI, PhD, director of the Penn Polyendocrine Metabolic Syndrome Center and Founder's Professor of Women's Health at the University of Pennsylvania, was one of the senior authors of the initial paper that announced the name change in The Lancet.
She told Healio that PCOS "was problematic" for two
Anuja Dokras, MD, MHCI, PhD, director of the Penn Polyendocrine Metabolic Syndrome Center and Founder's Professor of Women's Health at the University of Pennsylvania, was one of the senior authors of the initial paper that announced the name change in The Lancet.
Open the app view to save this story, compare related coverage, and continue from the same source.